Stockreport

ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

ChromaDex Corporation  (CDXC) 
NASDAQ:AMEX Investor Relations: investors.chromadex.com
PDF LOS ANGELES--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ: CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy-aging research, today anno [Read more]